{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:31:55Z","timestamp":1792783915123,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"crossref","award":["V105C-052"],"award-info":[{"award-number":["V105C-052"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ministry of Science and Technology, R.O.C.","award":["104\u20132314-B-010\u2013068-MY3"],"award-info":[{"award-number":["104\u20132314-B-010\u2013068-MY3"]}]},{"name":"Szu-Zuan Research Foundation of Internal Medicine, Taipei, R.O.C","award":["106002"],"award-info":[{"award-number":["106002"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.ejphar.2018.02.016","type":"journal-article","created":{"date-parts":[[2018,2,11]],"date-time":"2018-02-11T01:36:31Z","timestamp":1518312991000},"page":"133-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Effect of sirolimus on liver cirrhosis and hepatic encephalopathy of common bile duct-ligated rats"],"prefix":"10.1016","volume":"824","author":[{"given":"Kuo-Cheng","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Chun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Shin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiao-Lin","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Fang","family":"Hsin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Jung","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fa-Yauh","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Chih","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shou-Dong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2018.02.016_bib1","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1365-2982.2008.01132.x","article-title":"Indomethacin improves locomotor deficit and reduces brain concentrations of neuroinhibitory steroids in rats following portacaval anastomosis","volume":"20","author":"Ahboucha","year":"2008","journal-title":"Neurogastroenterol. Motil."},{"key":"10.1016\/j.ejphar.2018.02.016_bib2","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1124\/jpet.104.079616","article-title":"Long-term treatment of bile duct-ligated rats with rapamycin (sirolimus) significantly attenuates liver fibrosis: analysis of the underlying mechanisms","volume":"313","author":"Biecker","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2018.02.016_bib3","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.3748\/wjg.v20.i10.2555","article-title":"Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis","volume":"20","author":"Bolognesi","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2018.02.016_bib4","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/hep.21734","article-title":"Inflammation and hepatic encephalopathy: ibuprofen restores learning ability in rats with portacaval shunts","volume":"46","author":"Cauli","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2018.02.016_bib5","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejphar.2017.02.039","article-title":"Effects of raloxifene on portal hypertension and hepatic encephalopathy in cirrhotic rats","volume":"802","author":"Chang","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.02.016_bib6","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ejphar.2011.04.060","article-title":"Selective cyclooxygenase inhibition improves hepatic encephalopathy in fulminant hepatic failure of rat","volume":"666","author":"Chang","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.02.016_bib7","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neulet.2016.03.053","article-title":"Effects of rapamycin pretreatment on blood-brain barrier disruption in cerebral ischemia-reperfusion","volume":"620","author":"Chi","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2018.02.016_bib8","first-page":"G371","article-title":"Measurement of portal-systemic shunting in the rat by using \u03b3-labeled microspheres","volume":"240","author":"Chojkier","year":"1981","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2018.02.016_bib9","first-page":"263","article-title":"Establishment of an animal model of hepatic encephalopathy","volume":"63","author":"Chu","year":"2000","journal-title":"Zhonghua Yi Xue Za Zhi (Taipei)"},{"key":"10.1016\/j.ejphar.2018.02.016_bib10","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.dld.2012.02.005","article-title":"Phase II study of sirolimus in treatment-naive patients with advanced hepatocellular carcinoma","volume":"44","author":"Decaens","year":"2012","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.ejphar.2018.02.016_bib11","doi-asserted-by":"crossref","first-page":"492","DOI":"10.4049\/jimmunol.1501845","article-title":"Essential role of mTORC1 in self-renewal of murine alveolar macrophages","volume":"198","author":"Deng","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2018.02.016_bib12","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/stem.1265","article-title":"mTORC1 and mTORC2 play different roles in the functional survival of transplanted adipose-derived stromal cells in hind limb ischemic mice via regulating inflammation in vivo","volume":"31","author":"Fan","year":"2013","journal-title":"Stem Cells"},{"issue":"2","key":"10.1016\/j.ejphar.2018.02.016_bib13","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/gastro\/gox013","article-title":"Hepatic encephalopathy","volume":"5","author":"Ferenci","year":"2017","journal-title":"Gastroenterol. Rep. (Oxf.)."},{"key":"10.1016\/j.ejphar.2018.02.016_bib14","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/hep.21785","article-title":"Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats","volume":"46","author":"Fernandez","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2018.02.016_bib15","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1001\/archsurg.1979.01370330086016","article-title":"Portal hypertension after bile duct obstruction: effect of bile diversion on portal pressure in the rat","volume":"114","author":"Franco","year":"1979","journal-title":"Arch. Surg."},{"issue":"7","key":"10.1016\/j.ejphar.2018.02.016_bib16","doi-asserted-by":"crossref","first-page":"878","DOI":"10.7150\/ijbs.18976","article-title":"Inhibition of mTOR signaling confers protection against cerebral ischemic injury in acute hyperglycemic rats","volume":"13","author":"Hei","year":"2017","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ejphar.2018.02.016_bib17","first-page":"H1150","article-title":"On the validity of blood flow measurement using colored microspheres","volume":"276","author":"Hodeige","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2018.02.016_bib18","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.2337\/db09-1324","article-title":"Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue","volume":"59","author":"Houde","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2018.02.016_bib19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3389\/fgene.2015.00247","article-title":"Dose-dependent effects of mTOR inhibition on weight and mitochondrial disease in mice","volume":"6","author":"Johnson","year":"2015","journal-title":"Front. Genet."},{"issue":"6","key":"10.1016\/j.ejphar.2018.02.016_bib20","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/hep.21180","article-title":"Brain edema and inflammatory activation in bile duct ligated rats with diet-induced hyperammonemia: a model of hepatic encephalopathy in cirrhosis","volume":"43","author":"Jover","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2018.02.016_bib21","doi-asserted-by":"crossref","first-page":"7452","DOI":"10.3748\/wjg.v20.i23.7452","article-title":"Inhibitory effects of rapamycin on the different stages of hepatic fibrosis","volume":"20","author":"Kim","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2018.02.016_bib22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.28873","article-title":"Expression of scavenger receptor-AI promotes alternative activation of murine macrophages to limit hepatic inflammation and fibrosis","volume":"65","author":"Labonte","year":"2017","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.ejphar.2018.02.016_bib23","doi-asserted-by":"crossref","first-page":"e36322","DOI":"10.1371\/journal.pone.0036322","article-title":"Impairment of the organization of locomotor and exploratory behaviors in bile duct-ligated rats","volume":"7","author":"Leke","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ejphar.2018.02.016_bib24","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1096\/fj.201600495R","article-title":"mTORC1 pathway disruption ameliorates brain inflammation following stroke via a shift in microglia phenotype from M1 type to M2 type","volume":"30","author":"Li","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.ejphar.2018.02.016_bib25","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/jcbfm.2013.82","article-title":"Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer's disease","volume":"33","author":"Lin","year":"2013","journal-title":"J. Cereb. Blood Flow. Metab."},{"issue":"8","key":"10.1016\/j.ejphar.2018.02.016_bib26","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.7150\/ijbs.15624","article-title":"Rapamycin reduced ischemic brain damage in diabetic animals is associated with suppressions of mTOR and ERK1\/2 signaling","volume":"12","author":"Liu","year":"2016","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ejphar.2018.02.016_bib27","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1742-7843.2010.00544.x","article-title":"Effects of the non-competitive NMDA receptor antagonist memantine on the volitional consumption of ethanol by alcohol-preferring rats","volume":"106","author":"Malpass","year":"2010","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2018.02.016_bib28","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jhep.2010.01.004","article-title":"Relevance of the mTOR signaling pathway in the pathophysiology of splenomegaly in rats with chronic portal hypertension","volume":"52","author":"Mejias","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2018.02.016_bib29","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/hep.22758","article-title":"Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats","volume":"49","author":"Mejias","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2018.02.016_bib30","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.jhep.2006.07.030","article-title":"Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis","volume":"45","author":"Neef","year":"2006","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2018.02.016_bib31","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jcjo.2014.07.003","article-title":"Rapamycin inhibits oxidative and angiogenic mediators in diabetic retinopathy","volume":"49","author":"Ozdemir","year":"2014","journal-title":"Can. J. Ophthalmol."},{"key":"10.1016\/j.ejphar.2018.02.016_bib32","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1042\/CS20130081","article-title":"Everolimus is a potent inhibitor of activated hepatic stellate cell functions in vitro and in vivo, while demonstrating anti-angiogenic activities","volume":"126","author":"Piguet","year":"2014","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.ejphar.2018.02.016_bib33","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/hep.26109","article-title":"Inhibition of mammalian target of rapamycin aggravates the respiratory burst defect of neutrophils from decompensated patients with cirrhosis","volume":"57","author":"Rolas","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2018.02.016_bib34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0092-8674(94)90570-3","article-title":"RAFT1: a mammalian protein that binds to FKBP12 in a rapamycin-dependent fashion and is homologous to yeast TORs","volume":"78","author":"Sabatini","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2018.02.016_bib35","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jhep.2006.11.021","article-title":"Vascular remodeling and antitumoral effects of mTOR inhibition in a rat model of hepatocellular carcinoma","volume":"46","author":"Semela","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejphar.2018.02.016_bib36","doi-asserted-by":"crossref","first-page":"e83908","DOI":"10.1371\/journal.pone.0083908","article-title":"Rapamycin ameliorates inflammation and fibrosis in the early phase of cirrhotic portal hypertension in rats through inhibition of mTORC1 but not mTORC2","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2018.02.016_bib37","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1056\/NEJMra1600561","article-title":"Hepatic Encephalopathy","volume":"375","author":"Wijdicks","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2018.02.016_bib38","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1158\/1078-0432.CCR-06-0764","article-title":"Phase I\/II study of the mammalian target of rapamycin inhibitor everolimus (RAD001) in patients with relapsed or refractory hematologic malignancies","volume":"12","author":"Yee","year":"2006","journal-title":"Clin. Cancer Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918300943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918300943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T23:45:14Z","timestamp":1719791114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299918300943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":38,"alternative-id":["S0014299918300943"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.02.016","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of sirolimus on liver cirrhosis and hepatic encephalopathy of common bile duct-ligated rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}